“[Our study] shows that the majority of participants reported an improvement in their subjective sleep symptoms since commencing medical cannabis,” investigators concluded.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“The results demonstrate that all terpenes, when tested individually, activate CB1 receptors, at about 10-50 percent of the activation by THC alone,” researchers affirmed.
On a scale of zero (totally ineffective) to 10 (totally effective), 69 percent of users rated the effectiveness of cannabis as 7 or higher at relieving pelvic pain.
“Collectively, these in vitro and in vivo findings suggest that CBD exerts cell-specific effects which can be exploited to enhance bone metabolism,” authors concluded.
“The lack of accurate reporting can have impacts on medical patients controlling [their] dosage, recreational consumers expecting an effect aligned with price, and trust in the industry as a whole.”
“There was no significant association between any measure of cannabis use at baseline and either transition to psychosis, the persistence of symptoms, or functional outcomes,” researchers reported.
Eighty-seven percent of PD patients exhibited improvements following their use of medical cannabis tinctures.
Nearly one in four IBD patients report using cannabis.